MARKET WIRE NEWS

AWH Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Results and Conference Call Date

MWN-AI** Summary

Ascend Wellness Holdings, Inc. (AWH) recently announced its preliminary, unaudited financial results for the fourth quarter and full year 2025, highlighting a promising performance amidst ongoing industry challenges. For Q4 2025, AWH expects revenues of approximately $120 million, with an Adjusted EBITDA of around $30 million, yielding an impressive 25% margin. For the entire year 2025, the company anticipates revenues of about $500 million and an Adjusted EBITDA estimated at $117 million, reflecting a margin of roughly 23%.

The company's financial health remains robust, reporting approximately $86 million in cash and no significant debt repayments due until 2029. CEO Sam Brill noted that the results demonstrate effective working capital management and strategic shifts toward a customer-centric operating model. The company's densification strategy helped expand its retail presence to 47 stores, boosting its product and brand portfolio, which, in turn, supported market share growth across core markets.

Additionally, AWH faces an arbitration award favoring Green Thumb Industries, relating to a 2018 agreement. Although AWH disagrees with this decision, they assert sufficient liquidity to operate as planned, indicating they can manage the financial implications without jeopardizing operational integrity.

AWH has scheduled its earnings conference call for March 12, 2026, at 5:00 PM ET, where it will discuss these results further. Stakeholders can join via phone or a live webcast. This ongoing transparency is likely to resonate well with investors who value financial clarity. Overall, AWH appears to be entering 2026 from a fortified position with solid strategies laid out for growth and sustainability in the evolving cannabis market.

MWN-AI** Analysis

Ascend Wellness Holdings, Inc. (CSE: AAWH-U) recently announced preliminary, unaudited results for the fourth quarter and full year 2025, revealing a strong performance characterized by substantial revenue and EBITDA figures. For Q4 2025, the company projects net revenue of approximately $120 million, reflecting a solid performance amid a competitive market. The adjusted EBITDA for the same period is expected to be around $30 million, achieving a margin of approximately 25%. Full-year 2025 projections show net revenue nearing $500 million with an adjusted EBITDA of around $117 million, representing a 23% margin. This operational success emphasizes AWH's focus on disciplined cost control and a strategic product mix, bolstering their competitive position in the cannabis market.

Investors should view AWH's balance sheet positively, with a reported $86 million in cash and no significant debt obligations until 2029. This liquidity not only supports ongoing operations but also allows AWH the flexibility to pursue strategic initiatives or risk management strategies should any unforeseen challenges arise, such as the recent arbitration award involving Green Thumb Industries.

As AWH prepares to host its conference call on March 12, 2026, market participants should tune in for further insights into management's future strategies, particularly regarding their recent arbitration challenges and potential impacts on future earnings.

Given its current trajectory, positive cash flow, and operational strengths, AWH appears well-positioned for further growth. However, potential investors should monitor the outcomes related to the arbitration case as they could influence share performance. Long-term prospects seem promising, but investors may benefit from taking a cautious approach amid inherent sector volatility.

**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.

Source: Canada Newswire

Canada NewsWire

Q4 2025 and FY 2025 revenue expected to be ~$120 million and ~$500 million, respectively

Q4 2025 and FY 2025 Adjusted EBITDA projected at ~$30 million and ~$117 million

Balance sheet strength with $86 million cash and no significant debt maturities until 2029

Q4 & FY 2025 earnings call scheduled for Thursday, March 12, at 5:00 PM ET

NEW YORK, Feb. 9, 2026 /CNW/ - Ascend Wellness Holdings, Inc. ("AWH", "Ascend" or the "Company") (CSE: AAWH-U) (OTCQX: AAWH), a multi-state, vertically integrated cannabis operator, today announced preliminary, unaudited results for the fourth quarter and year ended December 31, 2025.

For the fourth quarter of 2025 ("Q4 2025"), the Company expects net revenue to be approximately $120 million and Adjusted EBITDA to be approximately $30 million, representing an Adjusted EBITDA margin of ~25%. For the full year 2025 ("FY 2025"), the Company expects net revenue to be approximately $500 million and Adjusted EBITDA to be approximately $117 million, with an Adjusted EBITDA margin of ~23%. As of December 31, 2025, the Company had cash and cash equivalents of approximately $86 million. 

"Our Q4 results delivered Adjusted EBITDA margin expansion in line with our guidance at the start of the year, driven by disciplined working capital management, cost controls, and an improved product and sales mix," said Sam Brill, Chief Executive Officer and Director of AWH. "Through our densification strategy, we expanded our retail footprint to 47 stores and deliberately reoriented the business toward a customer-focused, CPG operating model. This shift supported a record number of SKUs and a broader product and brand portfolio, driving market share gains across our core markets. These results underpin a strong business and balance sheet, backed by ample liquidity and a solid operational platform. We have entered 2026 in a position of strength, with no significant debt maturities until 2029, and a highly selective, disciplined approach to advancing our expansion pipeline and M&A initiatives."

Subsequent to the quarter, on February 5, 2026, the Company was notified of an arbitration award in favor of Green Thumb Industries, Inc. ("GTI") relating to a 2018 side letter tied to a prior capital raise. The arbitrator found both parties breached certain obligations under the agreement. The Company disagrees with the unanticipated decision, which was contrary to advice and guidance from expert external advisors and analyses. The Company is continuing to evaluate its options. Even if the Company were required to satisfy the award in full, it has sufficient liquidity and financial flexibility necessary to continue operating as planned and will remain in compliance with its loan covenants. For the complete filing, please refer to the Company's Form 8-K filed with the Securities Exchange Commission ("SEC") on February 6, 2026, available on the SEC's EDGAR website at www.sec.gov.         

Earnings Conference Call

The Company will hold a conference call on Thursday, March 12, 2026, at 5:00 PM ET, following the release of its complete fourth quarter and full year 2025 results.

The earnings conference call may be accessed by dialing 1-888-699-1199. A live webcast will also be available on the Investor Relations section of the AWH website at https://awholdings.com/investors and will be archived for replay.

CONFERENCE CALL DETAILS

 

DATE:

Thursday, March 12, 2026

TIME:

5:00 p.m. ET

WEBCAST:

Click to access

DIAL-IN NUMBER:     

1-888-699-1199

REPLAY:

1-888-660-6345

Replay Code: 66620#
Available until 12:00 midnight ET Thursday, March 19, 2026

Non-GAAP Financial Information and Definitions

This press release includes certain non-GAAP financial measures as defined by the U.S. Securities and Exchange Commission ("SEC"). This information should be considered as supplemental in nature and not as a substitute for, or superior to, any measure of performance prepared in accordance with GAAP. 

Adjusted EBITDA/Margin are non-GAAP financial measures.

Our "Adjusted EBITDA" is a non-GAAP measure used by management that is not defined by GAAP and may not be comparable to similar measures presented by other companies. We define "Adjusted EBITDA Margin" as Adjusted EBITDA as a percentage of net revenue. Management calculates Adjusted EBITDA as the reported net loss, adjusted to exclude: income tax expense, other (income) expense, interest expense, depreciation and amortization, depreciation and amortization included in cost of goods sold, non-cash inventory adjustments, equity-based compensation, equity-based compensation included in cost of goods sold, start-up costs, start-up costs included in cost of goods sold, transaction-related and other non-recurring expenses, and gain or loss on sale of assets. Accordingly, management believes that Adjusted EBITDA provides meaningful and useful financial information, as this measure demonstrates the operating performance of the business. Non-GAAP financial measures may be considered in addition to the results prepared in accordance with GAAP, but they should not be considered a substitute for, or superior to, GAAP results. The Company's presentation of these financial measures may not be comparable to similar non-GAAP measures used by other companies. These financial measures are intended to provide additional information to investors regarding the Company's performance.

About Ascend Wellness Holdings, Inc.

AWH is a vertically integrated cannabis operator with assets in Illinois, Maryland, Massachusetts, Michigan, New Jersey, Ohio and Pennsylvania. AWH owns and operates state-of-the-art cultivation facilities, growing award-winning strains and producing a curated selection of products for retail and wholesale customers. AWH produces and distributes its in-house Simply Herb, Ozone, Ozone Reserve, High Wired, Honor Roll, Effin', Common Goods, and Royale branded products. For more information about AWH, visit www.awholdings.com.

Caution Regarding Pre-Released Financial Metrics

This press release contains certain pre-released fourth quarter and full year financial metrics. The fourth quarter and full year financial metrics contained in this press release are preliminary and unaudited and represent the most current information available to the Company's management, as financial closing procedures for the three months and year ended December 31, 2025 are not yet complete. The Company's actual consolidated audited financial statements for such period will be filed with the applicable Canadian securities administrators on its profile on SEDAR at https://www.sedarplus.ca/and the SEC on its profile on EDGAR at www.sec.gov, and may result in material changes to the financial metrics summarized in this press release (including by any one financial metric, or all of the financial metrics, being below or above the figures indicated) as a result of the completion of normal quarter and year-end accounting procedures and adjustments, and also what one might expect to be in the final consolidated financial statements based on the financial metrics summarized in this press release. Although the Company believes the expectations reflected in this press release are based upon reasonable assumptions, the Company can give no assurance that actual results will not differ materially from these expectations.

Cautionary Note Regarding Forward-Looking Information

This news release includes forward-looking information and statements (together, "forward-looking statements"), which may include, but are not limited to, the plans, intentions, expectations, estimates, and beliefs of the Company. Words such as "expects", "continue", "may", "will", "anticipates", and "intends" or similar expressions are intended to identify forward-looking statements. Without limiting the generality of the preceding statement, all statements in this press release relating to estimated and projected revenue, expectations regarding production capacity, anticipated capital expenditures, expansion, profit, product demand, margins, costs, cash flows, sources of capital, growth rates, potential acquisitions, closing dates for transactions, regulatory approvals, future facility openings, and, enhancing shareholder value, reducing downward pressure on the stock, and future financial and operating results, including expectations regarding liquidity, cash flows, and the financial impact or resolution of legal or arbitration matters are forward-looking statements.

We caution investors that any such forward-looking statements are based on the Company's current projections and expectations about future events and financial trends, the receipt of all required regulatory approvals, and on certain assumptions and analysis made by the Company in light of the experience of the Company and perception of historical trends, current conditions, and expected future developments and other factors management believes are appropriate.

Forward-looking statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking statements herein. Such factors include, among others, the risks and uncertainties identified in the Company's most recently filed Annual Report on Form 10-K, as updated in subsequently filed Quarterly Reports on Form 10-Q, as applicable, and in the Company's other reports and filings with the applicable Canadian securities administrators on its profile on SEDAR+ at www.sedarplus.ca and the SEC on its profile on EDGAR at www.sec.gov. Although the Company believes that any forward-looking statements herein are reasonable, in light of the use of assumptions and the significant risks and uncertainties inherent in such statements, there can be no assurance that any such forward-looking statements will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking statements. Any forward-looking statements herein are made as of the date hereof, and except as required by applicable laws, the Company assumes no obligation and disclaims any intention to update or revise any forward-looking statements herein or to update the reasons that actual events or results could or do differ from those projected in any forward-looking statements herein, whether as a result of new information, future events or results, or otherwise, except as required by applicable laws. No securities regulator nor the Canadian Securities Exchange has reviewed, approved, or disapproved the content of this press release.

SOURCE Ascend Wellness Holdings, Inc.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/February2026/09/c7468.html

FAQ**

What specific factors contributed to the expected revenue of approximately $120 million for Q4 2025 and $500 million for FY 2025 for Ascend Wellness Holdings Inc Cl A AAWH?

The expected revenue for Ascend Wellness Holdings Inc Cl A in Q4 and FY 2025 is driven by factors such as increased market share, expansion of retail locations, robust product demand, strategic partnerships, and overall growth in the cannabis industry.

How does the Adjusted EBITDA margin of ~25% for Q4 20and ~23% for FY 20reflect Ascend Wellness Holdings Inc Cl A AAWH's operational efficiency and cost management strategy?

The Adjusted EBITDA margins of ~25% for Q4 2025 and ~23% for FY 2025 indicate that Ascend Wellness Holdings Inc Cl A AAWH has effectively optimized its operational efficiency and implemented strong cost management strategies, enhancing profitability and sustaining competitive advantage.

Can you elaborate on the impact of the recent arbitration award involving Green Thumb Industries, Inc. on the financial outlook and operations of Ascend Wellness Holdings Inc Cl A AAWH?

The recent arbitration award favoring Green Thumb Industries, Inc. could negatively affect Ascend Wellness Holdings Inc (AAWH) by increasing competitive pressure and potentially impacting investor sentiment, which may alter its financial outlook and operational strategy.

What specific expansion plans and M&A initiatives does Ascend Wellness Holdings Inc Cl A AAWH intend to pursue in 2026, in light of its strong balance sheet and cash position?

As of October 2023, Ascend Wellness Holdings Inc Cl A (AAWH) is expected to leverage its robust balance sheet and cash position to pursue targeted market expansions and strategic acquisitions in high-growth regions to enhance its operational footprint in 2026.

**MWN-AI FAQ is based on asking OpenAI questions about Ascend Wellness Holdings Inc Cl A (OTC: AAWH).

Ascend Wellness Holdings Inc Cl A

NASDAQ: AAWH

AAWH Trading

9.11% G/L:

$0.5583 Last:

537 Volume:

$0.558339 Open:

mwn-ir Ad 300

AAWH Latest News

AAWH Stock Data

$111,908,350
143,238,815
N/A
1
N/A
Pharmaceuticals
Healthcare
US
Morristown

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App